| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.ARR.2017.12.007 |
| P698 | PubMed publication ID | 29288112 |
| P50 | author | Hao Deng | Q63148473 |
| P2093 | author name string | Peng Wang | |
| Joseph Jankovic | |||
| P2860 | cites work | Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 72-85 | |
| P577 | publication date | 2017-12-26 | |
| P1433 | published in | Ageing Research Reviews | Q762802 |
| P1476 | title | The genetics of Parkinson disease | |
| P478 | volume | 42 |
| Q64786579 | Q64786579 |
| Q91861291 | A course-based undergraduate research experience examining neurodegeneration in Drosophila melanogaster teaches students to think, communicate, and perform like scientists |
| Q89547719 | Associations between migraine occurrence and the effect of aura, age at onset, family history, and sex: A cross-sectional study |
| Q64786345 | Autonomic dysfunction in Parkinson disease and animal models |
| Q64763405 | Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery |
| Q64881160 | Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum. |
| Q58765503 | CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease |
| Q92703211 | Case of Early-Onset Parkinson's Disease in a Heterozygous Mutation Carrier of the ATP7B Gene |
| Q93108820 | Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease |
| Q52351688 | Current perspective of mitochondrial biology in Parkinson's disease. |
| Q58696340 | Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress |
| Q97518174 | Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis |
| Q98185956 | Effects on Dopaminergic Neurons Are Secondary in COX-Deficient Locomotor Dysfunction in Drosophila |
| Q64071921 | Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD |
| Q60915121 | Essential Tremor and Parkinson's Disease: Exploring the Relationship |
| Q92084092 | Golgi Fragmentation in Neurodegenerative Diseases: Is There a Common Cause? |
| Q60935443 | Impact of Nanoparticles on Brain Health: An Up to Date Overview |
| Q97882905 | Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson's Disease |
| Q58604362 | Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations |
| Q58544845 | JNK-mediated phosphorylation of SARM1 regulates NAD cleavage activity to inhibit mitochondrial respiration |
| Q55410950 | LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review. |
| Q64093476 | Lipostatic Mechanisms Preserving Cerebellar Lipids in MPTP-Treated Mice: Focus on Membrane Microdomains and Lipid-Related Gene Expression |
| Q64898499 | MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson's Disease. |
| Q91786444 | Microglia in neurodegeneration |
| Q91893755 | NCS-1 Deficiency Affects mRNA Levels of Genes Involved in Regulation of ATP Synthesis and Mitochondrial Stress in Highly Vulnerable Substantia nigra Dopaminergic Neurons |
| Q92592366 | Novel Compound Heterozygous PRKN Variants in a Han-Chinese Family with Early-Onset Parkinson's Disease |
| Q90482186 | Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1 |
| Q92498342 | Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity |
| Q64083810 | POLG R964C and GBA L444P mutations in familial Parkinson's disease: Case report and literature review |
| Q93217394 | Parkinson disease and the immune system - associations, mechanisms and therapeutics |
| Q60923524 | Parkinson's disease and Alzheimer's disease: a Mendelian randomization study |
| Q57458019 | Physiological carboxy-truncation of α-synuclein potentiates the prion-like formation of pathological inclusions |
| Q90181986 | Potential Roles of Exosomes in Parkinson's Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis |
| Q58572579 | Recent Advances in Biomarkers for Parkinson's Disease |
| Q88316783 | Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities |
| Q64770079 | Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors |
| Q55437754 | Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer. |
| Q64243678 | Switching on Endogenous Metal Binding Proteins in Parkinson's Disease |
| Q89860571 | The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers |
| Q61804251 | The Role of Lipids in Parkinson's Disease |
| Q58726908 | The Role of TMEM230 Gene in Parkinson's Disease |
| Q57175337 | The Therapeutic Potential of Metformin in Neurodegenerative Diseases |
| Q64779716 | The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru |
| Q91606425 | The mitochondrial metabolic function of DJ-1 is modulated by 14-3-3β |
| Q93060745 | Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression |
| Q64785431 | [Genetics of movement disorders-rare but important] |
Search more.